## Abstract A temperature‐sensitive mouse fibroblast cell line was used to examine the relationship between hexose sugar uptake rates and the control of cell growth. The cell line used (ts‐H6‐15) is a derivative of SV‐3T3 cells, exhibiting a transformed phenotype at 32°C and a normal phenotype at 3
Activation of the inositol trisphosphate second messenger system by cAMP in a mouse fibroblast cell line
✍ Scribed by Valerie J. Horn; Paul A. Sheehy; Miriam B. Goodman; Indu S. Ambudkar
- Publisher
- Springer
- Year
- 1991
- Tongue
- English
- Weight
- 569 KB
- Volume
- 101
- Category
- Article
- ISSN
- 0300-8177
No coin nor oath required. For personal study only.
✦ Synopsis
Intracellular Ca2+ mobilization events were assessed in mouse L cells, which contain native prostaglandin E1 receptors and transfected human beta 2 adrenergic receptors. Both Fura2 (single cell measurements) and Quin 2, (cuvette assays) were used to determine [Ca2+]i levels. Our results demonstrate that in the transfected cells there is a dose-dependent increase in [Ca2+]i in response to isoproterenol (0.1 nM-100 nM), which is inhibited by the beta-adrenergic antagonist, propranolol, and is a result of intracellular Ca2+ release. [Ca2+]i in these cells was also increased by prostaglandin E1, 8 bromo cyclic AMP, and aluminum fluoride. Both 8 bromo cAMP and isoproterenol induced a rapid increase in the levels of IP1, IP2, and IP3. The data presented demonstrate that the elevation of intracellular cyclic AMP induces an increase in IP3 production which leads to an elevation in [Ca2+]i. We propose that this cyclic AMP dependent activation of the IP3 generating system occurs at a post-receptor site.
📜 SIMILAR VOLUMES
## Abstract To analyze the role of S19 ribosomal protein (RP S19) in apoptosis, murine NIH3T3 were transfected with either hemagglutinin peptide‐tagged (HA) wild‐type human RP S19 or a mutant (Gln137Asn) that is resistant to transglutaminase‐catalyzed cross‐linked‐dimerization. Transfection with th
## Abstract Glial cell line‐derived neurotrophic factor (GDNF) has been shown to be neuroprotective in animal models of the dopamine deficiency in Parkinson's disease. To examine the role of the extracellular signal‐regulated kinases 1 and 2 (ERK1/2) in this process, we infused a single dose of GDN